Literature DB >> 2454889

Interferons.

A G Morris1.   

Abstract

Interferon (IFN)-alpha and -beta are produced by virus-infected cells; IFN-gamma is produced as a primary response of T lymphocytes to mitogenic stimulation, IFN-gamma gene activation being brought about by changes in Ca2+ and phosphatidyl inositol metabolism. IFNs act by binding to cell surface receptors and triggering activation of IFN-responsive genes, probably via specific base sequences located in the 5' non-coding region of such genes, resulting in changes in cell function. Important genes activated in this way are the MHC antigen genes; class I induced by all IFNs, class II by IFN-gamma only. This MHC activation may have important consequences for lymphocyte function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454889

Source DB:  PubMed          Journal:  Immunol Suppl        ISSN: 0953-4954


  5 in total

1.  T cells augment monocyte and neutrophil function in host resistance against oropharyngeal candidiasis.

Authors:  C S Farah; S Elahi; G Pang; T Gotjamanos; G J Seymour; R L Clancy; R B Ashman
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Immunoreactive alpha interferon in cervical flat koilocytic lesions and intraepithelial neoplasia.

Authors:  C J Stewart; M A Farquharson; A M McNicol; A K Foulis
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

Review 3.  Electrochemical sensing: A prognostic tool in the fight against COVID-19.

Authors:  Sharda Kotru; Martin Klimuntowski; Hashim Ridha; Zakir Uddin; Ali A Askhar; Gurmit Singh; Matiar M R Howlader
Journal:  Trends Analyt Chem       Date:  2021-01-23       Impact factor: 14.908

Review 4.  A comprehensive review of adverse events to drugs used in COVID-19 patients: Recent clinical evidence.

Authors:  Renato Ferreira-da-Silva; Inês Ribeiro-Vaz; Manuela Morato; Jorge Junqueira Polónia
Journal:  Eur J Clin Invest       Date:  2022-02-27       Impact factor: 5.722

Review 5.  COVID-19 and Myositis: What We Know So Far.

Authors:  Ahmad Saud; R Naveen; Rohit Aggarwal; Latika Gupta
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.